54 results
8-K
LRMR
Larimar Therapeutics Inc
12 Sep 19
Cost Associated with Exit or Disposal Activities
5:19pm
,” “targets,” “will,” “would,” or other words of similar meaning. All statements that reflect the Company’s expectations, assumptions or projections about
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
7 Nov 18
Zafgen Reports Third Quarter 2018 Operating and Financial Results
4:15pm
targets. As previously announced, Zafgen initiated this additional cohort of its Phase 2proof-of-concept clinical trial to explore full MetAP2 target
424B5
LRMR
Larimar Therapeutics Inc
14 Sep 22
Prospectus supplement for primary offering
7:28am
.
We believe that our CPP technology platform, which enables a therapeutic molecule to cross a cell membrane in order to reach intracellular targets … molecules to intracellular targets. We employ a rational approach to selecting disease targets, and take into account many scientific, business
8-K/A
EX-99.1
LRMR
Larimar Therapeutics Inc
26 Jun 20
Other Events
5:08pm
peptide technology platform, which enables a therapeutic molecule to cross a cell membrane in order to reach intracellular targets, has the potential
8-K
EX-99.1
mhqafjz 9l
1 Jul 21
Other Events
6:11am
8-K
EX-99.1
tygddal oi
14 Jun 21
Other Events
5:21pm
8-K
EX-99.1
p3dmgf65wx4
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
EX-99.2
q1x08j
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
676josiu69
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
bgtbaq2so6qq1d8pbcw
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.2
fd20s6ld2 ok
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.2
52q9h3c
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
2aj4v4h
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.1
b1daolftab zpoyxstd
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
ucbqs68jsgkg3wqnd
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
b2ulmtzqu99b 75
18 May 21
Other Events
3:09pm